Beyond sepsis: Activated protein C and heat stroke

Critical Care Medicine

Volumn 34, Issue 7, 2006, Pages 2020-2021

  Brueckmann, Martina ^a   Hoffmann, Ursula ^a   Borggrefe, Martin ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Activated protein C; Coagulation; Heat stroke; Inflammation; Sepsis

Indexed keywords

ACTIVATED PROTEIN C; CORTICOSTEROID; DROTRECOGIN; HYDROCORTISONE;

CLINICAL TRIAL; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; EDITORIAL; HUMAN; LOW DRUG DOSE; NONHUMAN; PRIORITY JOURNAL; SEPSIS; SINGLE DRUG DOSE;

ANIMALS; ANTI-INFECTIVE AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; HEAT STROKE; PROTEIN C; RATS; RECOMBINANT PROTEINS;

EID: 33745587027     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000221923.21401.71     Document Type: Editorial

References (14)

1. Grynszpan D: Lessons from the French heat-wave. Lancet 2003; 362:1169-1170
2. Bouchama A, Knochel JP: Heat stroke. N Engl J Med 2002; 346:1978-1988
3. Liu CC, Chien CH, Lin MT: Glucocorticoids reduce interleukin-1 concentration and result in neuroprotective effects in rat heat-stroke. J Physiol 2000; 527:333-343
4. Annane D, Sebille V, Charpentier C, et al: Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002; 288:862-871
5. Chen CM, Hou CC, Cheng KC, et al: Activated protein C therapy in a rat heat stroke model. Crit Care Med 2006; 34:1960-1966
6. Bernard GR, Vincent JL, Laterre PF, et al: Efficacy and safety of recombinant activated protein C for severe sepsis. N Engl J Med 2001; 344:699-709
7. Vincent JL, Bernard G, Beale R, et al: Drotrecogin alfa (activated) treatment in severe sepsis from the global open-label trial ENHANCE: Further evidence for survival and safety and implications for early treatment. Crit Care Med 2005; 33:2266-2277
8. Zeng W, Matter WF, Yan SB, et al: Effect of drotrecogin alfa (activated) on human endothelial cell permeability and Rho kinase signaling. Crit Care Med 2004; 32:S302-S308
9. Hoffmann JN, Vollmar B, Laschke MW, et al: Microcirculatory alterations in ischemia-reperfusion injury and sepsis: Effects of activated protein C and thrombin inhibition. Crit Care 2005; 9:S33-S37
10. Nick JA, Coldren CD, Geraci MW, et al: Recombinant human activated protein C reduces human endotoxin-induced pulmonary inflammation via inhibition of neutrophil chemotaxis. Blood 2004; 104:3878-3885
11. Mizutani A, Okajima K, Uchiba M, et al: Activated protein C reduces ischemia/reperfusion-induced renal injury in rats by inhibiting leukocyte activation. Blood 2000; 95:3781-3787
12. Shibata M, Kumar R, Amar A, et al: Anti-inflammatory, antithrombotic and neuroprotective effects of activated protein C in a murine model of focal ischemic stroke. Circulation 2001; 103:1799-1805
13. Schoots IG, Levi M, van Vliet AK, et al: Inhibition of coagulation and inflammation by activated protein C or antithrombin reduces intestinal ischemia/reperfusion injury in rats. Crit Care Med 2004; 32:1375-1383
14. Bouchama A, Roberts G, Al Mohanna F, et al: Inflammatory, hemostatic, and clinical changes in a baboon experimental model for heatstroke. J Appl Physiol 2005; 98:697-705